Skip to content

LENSAR, Inc. LNSR Shares (Diluted)

Shares (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Staar Surgical logo
Staar SurgicalSTAA
50.9M+3.2%
Bausch + Lomb logo
Bausch + LombBLCO
355.2M+0.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
29.5M+6.6%
Schering-Plough logo
Schering-PloughSGP
19.9M+794%
IAR
Integra LifeSciencesIART
77M+0.6%

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s shares (diluted)?
LENSAR, Inc. (LNSR) reported shares (diluted) of 15.4M in Q1 2026.
How has LENSAR, Inc.'s shares (diluted) changed year-over-year?
LENSAR, Inc.'s shares (diluted) increased by 31.0% year-over-year, from 11.8M to 15.4M.
What is the long-term trend for LENSAR, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), LENSAR, Inc.'s shares (diluted) has grown at a 6.4% compound annual growth rate (CAGR), from 37.3M to 47.7M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.